skip to content

Early Cancer Institute

 
Read more at: Early career researchers successfully awarded ACED funding
International Alliance for Cancer Early Detection (ACED) Logo

Early career researchers successfully awarded ACED funding

14 November 2022

Two early career researchers from the University of Cambridge have been awarded ACED Early Career Pathway awards in the latest round of funding announced by CRUK’s International Alliance for Cancer Early Detection (ACED).


Read more at: Screening more and screening better: New recommendations for cancer screening published by European Union
EU cancer screening recommendations 2022

Screening more and screening better: New recommendations for cancer screening published by European Union

5 October 2022

Extended access to existing screening programmes and introduction of three new screening programmes are the recommendations made in the final report from the European Commission’s group of Chief Scientific Advisors, co-chaired by Early Cancer Institute Director Professor Rebecca Fitzgerald. The proposed Recommendation...


Read more at: Harvey Dev awarded grant extension to further prostate cancer research
Prostate Cancer Research logo

Harvey Dev awarded grant extension to further prostate cancer research

4 October 2022

Congratulations to Dr Harveer Dev who has been awarded a grant extension by Prostate Cancer Research to develop his new ProCASP tool, a CRISPR-Cas9 dynamic screening platform for prostate cancer.


Read more at: Early Cancer Institute launched at the University of Cambridge
Prof Sir Bruce Ponder toasts new Institute

Early Cancer Institute launched at the University of Cambridge

27 September 2022

Wednesday 21 st September saw the official launch of the Early Cancer Institute at the University of Cambridge. Located in the Hutchison building on the Cambridge biomedical campus, the Institute is the first physical location in the UK solely dedicated to research into Early Cancer. The launch event commenced with a lunch...


Read more at: Inside the new institute looking at early cancer
Professor Rebecca Fitzgerald in the lab

Inside the new institute looking at early cancer

21 September 2022

The Early Cancer Institute at the University of Cambridge aims to help create a world where we can detect cancer early enough to cure it. It is the first physical institute in the UK dedicated to understanding early cancer. As it hosts its official launch event, find out more about the pioneering research and the scientists within it.


Read more at: Matt Hoare receives CRUK Programme Foundation Award to explore liver cancer development
CRUK Programme Foundation Award

Matt Hoare receives CRUK Programme Foundation Award to explore liver cancer development

20 September 2022

New grant will enable research into the link between chronic liver disease and liver cancer.


Read more at: Charlie Massie wins Prostate Cancer UK research award
Prostate Cancer Research logo

Charlie Massie wins Prostate Cancer UK research award

13 September 2022

Charlie Massie has been awarded a Prostate Cancer UK research award to investigate the epigenetic evolution of prostate cancer. Epigenetics is the study of how your own behaviours and environment can cause changes that affect the way your genes work, without changing our DNA. Epigenetics has been linked to a number of...


Read more at: Interview with Professor Serena Nik-Zainal: Investigating the imprints of cancer
Professor Serena Nik-Zainal

Interview with Professor Serena Nik-Zainal: Investigating the imprints of cancer

15 August 2022

Early Cancer Institute Group Leader, Professor Serena Nik-Zainal, is at the forefront of genomic research, creating tools for clinicians which are transforming patient care. She was recently interviewed for This Cambridge Life, a series of stories from the people that make Cambridge University unique.


Read more at: Focus on urinary problems impacts effective prostate cancer diagnosis

Focus on urinary problems impacts effective prostate cancer diagnosis

4 August 2022

Prostate cancer is the most common type of cancer in men. According to Cancer Research UK, over 52,000 men are diagnosed with prostate cancer each year and there are more than 12,000 deaths. Over three-quarters (78%) of men diagnosed with the disease survive for over ten years, but this proportion has barely changed over...


Read more at: CRUK Open Lab Initiative connects cancer researchers across the UK

CRUK Open Lab Initiative connects cancer researchers across the UK

21 July 2022

The Cancer Research UK Open Lab Initiative connects research groups with shared interests to spark discussion, stimulate fresh ideas and generate new collaborations. It aims to help teams who are looking for new opportunities to exchange scientific ideas and interact more closely with other cancer research groups. They are...